|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $1,642,234 and $835,007 as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||
| Due from related party | ||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||
| Current assets from discontinued operations | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Investments held in Trust Account | ||||||||||||||||||
| Note receivable, related party | ||||||||||||||||||
| Unlabeled Abstract | ||||||||||||||||||
| Non-current assets | ||||||||||||||||||
| Long-term investments | ||||||||||||||||||
| Right-of-use assets, net | ||||||||||||||||||
| Nonrelated party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total right-of-use assets, net | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||
| Non-Current assets from discontinued operations | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||
| Excise tax payable | ||||||||||||||||||
| Deferred revenue | ||||||||||||||||||
| Due to related party | ||||||||||||||||||
| Accrued interest on Exchange Note | ||||||||||||||||||
| Accrued interest on Exchange and Additional Bridge Notes | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Nonrelated party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total operating lease liabilities | ||||||||||||||||||
| Financing lease liabilities | ||||||||||||||||||
| Factoring payable | ||||||||||||||||||
| Encompass Purchase Liability | ||||||||||||||||||
| Income tax payable | ||||||||||||||||||
| Advances from related parties | ||||||||||||||||||
| Convertible notes, at fair value | ||||||||||||||||||
| Additional Bridge Promissory note | ||||||||||||||||||
| Promissory note - M2B | ||||||||||||||||||
| Exchange Note | ||||||||||||||||||
| Extension Notes | ||||||||||||||||||
| Bridge Notes | ||||||||||||||||||
| Investor Note | ||||||||||||||||||
| Additional Bridge Notes | ||||||||||||||||||
| September 2024 Convertible Note | ||||||||||||||||||
| Exchange Note | ||||||||||||||||||
| Additional Bridge Notes | ||||||||||||||||||
| Quantum Convertible Note, related party at fair value | ||||||||||||||||||
| Loan payable, related party, net of discount | ||||||||||||||||||
| Line of credit | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total loan payable, related party, net of discount | ||||||||||||||||||
| Line of credit and note payable, net of discount | ||||||||||||||||||
| Line of credit | ||||||||||||||||||
| Equity Line of Credit | ||||||||||||||||||
| Line of credit | ||||||||||||||||||
| Equity Line of Credit | ||||||||||||||||||
| Promissory Note - related party | ||||||||||||||||||
| Bifurcated Derivative | ||||||||||||||||||
| Extension Notes | ||||||||||||||||||
| Bridge Notes | ||||||||||||||||||
| Investor Note | ||||||||||||||||||
| ELOC Commitment Fee Note | ||||||||||||||||||
| Notes payable, net of discount | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total notes payable, net of discount | ||||||||||||||||||
| Common stock issuance obligation | ||||||||||||||||||
| Due on share purchase | ||||||||||||||||||
| Contingent liability | ||||||||||||||||||
| Current liabilities from discontinued operations | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||
| Notes payable, less current portion, net of discount | ||||||||||||||||||
| SEPA liability | ||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||
| Nonrelated party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total operating lease liabilities, less current portion | ||||||||||||||||||
| Financing lease liability, less current portion | ||||||||||||||||||
| Deferred revenue, net of current portion | ||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Commitments and Contingencies (Note 11) | ||||||||||||||||||
| Common stock subject to possible redemption, $0.0001 par value; 114,966 shares issued and outstanding at redemption value of $11.15 per share as of March 31, 2024 and December 31, 2023 | ||||||||||||||||||
| Common Stock Subject to Redemption | ||||||||||||||||||
| Total common stock subject to possible redemption, $0.0001 par value; 114,966 shares issued and outstanding at redemption value of $11.15 per share as of March 31, 2024 and December 31, 2023 | ||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||
| Common stock, $0.0001 par value; 100,000,000 shares authorized; 55,679,813 and 33,193,140 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||
| Common Stock Not Subject to Possible Redemption | ||||||||||||||||||
| Total common stock, $0.0001 par value; 100,000,000 shares authorized; 55,679,813 and 33,193,140 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||
Loading...
